Evidence map›Paper›PMID 35491843›Full record

ArticlemSphere2022

Nuclear Magnetic Resonance Metabolomics of Symbioses between Bacterial Vaginosis-Associated Bacteria.

Victoria Horrocks, Charlotte K Hind, Matthew E Wand, Paul-Enguerrand Fady, Joel Chan, Jade C Hopkins, Georgina L Houston, Rachel M Tribe, J Mark Sutton, A James Mason

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Neonatal Microbiome: Is it Still Beneficial?Endocrine, metabolic & immune disorders drug targets · 2024
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Victoria HorrocksInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Charlotte K HindTechnology Development Group, Research and Evaluation Division, UK Health Security Agency, Salisbury, United Kingdom.
Matthew E WandTechnology Development Group, Research and Evaluation Division, UK Health Security Agency, Salisbury, United Kingdom.ORCID 0000-0002-9277-8869
Paul-Enguerrand FadyInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Joel ChanInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Jade C HopkinsInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Georgina L HoustonInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Rachel M TribeDepartment of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
J Mark SuttonInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
A James MasonInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.ORCID 0000-0003-0411-602X
King's College London · GBUK Health Security Agency · GB

Funding

Biotechnology and Biological Sciences Research Council 2081638British Heart FoundationDepartment of HealthWellcome Trust
6 · The paper itself

Abstract

Bacterial vaginosis (BV) is a dysbiosis of the vaginal microbiome, characterized by low levels of lactobacilli and overgrowth of a diverse group of bacteria, associated with higher risk of a variety of infections, surgical complications, cancer, and preterm birth (PTB). Despite the lack of a consistently applicable etiology,

Indexed as

Premature BirthVaginosis, BacterialBacteriaFemaleHumansInfant, NewbornLactobacillusMagnetic Resonance SpectroscopyPregnancySymbiosisAtopobium vaginaebacterial vaginosisGardnerellaGardnerella vaginalisMobiluncusMobiluncus curtisiiPeptostreptococcusPeptostreptococcus anaerobiuspreterm birthPrevotella biviaspontaneous preterm birthvaginal microbiome

Identifiers

PMID35491843
PMCPMC9241533
OpenAlexW4225273842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.